News

BioMed SA eyes new road map to greater economic wins

BioMed SA President Ann Stevens (Photo by Lyndsey Johnson) By W. Scott Bailey, San Antonio Business ...

Military champion has Prytime Medical ready for prime time

Prytime Medical Devices Inc. CEO David Spencer said his company is poised to take its flagship technology ...

Industry Publications

The Mission

The Mission is published by the University of Texas Health Science Center.

UTSA Discovery

UTSA Discovery is published annually for the Office of the Vice President for Research by the Office ...

News
Medical Device Firm Innovative Trauma Careā„¢ Names Philip W. Faris Executive Chairman of the Board of Directors
April 5, 2012

[Edmonton, Alberta, Canada]  Innovative Trauma CareTM (ITC), an early stage medical device company focused on developing and marketing point of injury solutions to the first responder, military and trauma markets, has named Philip W. Faris Executive Chairman of the Board of Directors.  In this role, Faris will provide experienced leadership and guidance for the company as it secures initial and subsequent funding and commercializes its first product, the ITClampTM, a hemorrhage control device.

Faris has a distinguished track record of building market-leading companies in emerging medical markets and has successfully performed as CEO for over three decades in start-up, early stage, and high-growth organizations.  He is currently CEO and managing partner at ProSavant International, a strategic consulting firm for the medical device and biotechnology space. He also serves on the Executive Committee of BiomedSA, a non-profit organization promoting the bioscience industry in San Antonio, Texas, as well as acts as a Board Member and Senior Advisor for Vivo Biosciences, an Alabama-based biotechnology company.  Through his career, Faris has acted as CEO and Director at Vidacare Corporation, VidiMedix Corporation, Trestle Corporation, Diatek Corporation and many other medical device, biotechnology and health care companies.

"We are thrilled to have an internationally-respected thought leader like Phil on board as we take our novel new technology to the world," commented ITC's founder and CEO Cdr (Ret'd) Dennis Filips, MD, FRCSC.  "Phil's deep knowledge of our primary markets as well as his proven ability to transform emerging technologies into practice standards will help us realize our long term goals."

ITC expects to launch its first product, the ITClamp, in late 2012.  The ITClamp addresses massive hemorrhage - a leading cause of death in traumatic injury - by controlling critical bleeding in under 3 seconds.  The clamping device works by sealing the skin closed to create a temporary pool of blood under pressure, which forms a stable clot until the wound can be surgically repaired.

Incorporated in 2010 and based in Edmonton, Canada, Innovative Trauma Care is addressing unmet needs in the field of emergency medicine by developing, manufacturing, and commercializing point of injury solutions to treat common causes of preventable death in traumatic injury scenarios.

 

Stay informed. Subscribe to BioMed SA news alerts.